8
Views
33
CrossRef citations to date
0
Altmetric
Article

Combined Vhlh and Pten Mutation Causes Genital Tract Cystadenoma and Squamous Metaplasia

, , , , , , & show all
Pages 4536-4548 | Received 30 Nov 2007, Accepted 30 Apr 2008, Published online: 27 Mar 2023

REFERENCES

  • Burgering, B. M., and R. H. Medema. 2003. Decisions on life and death: FOXO forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73:689–701.
  • Cantley, L. C., and B. G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96:4240–4245.
  • Chi, J. T., Z. Wang, D. S. Nuyten, E. H. Rodriguez, M. E. Schaner, A. Salim, Y. Wang, G. B. Kristensen, A. Helland, A. L. Borresen-Dale, A. Giaccia, M. T. Longaker, T. Hastie, G. P. Yang, M. J. van de Vijver, and P. O. Brown. 2006. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 3:e47.
  • Choyke, P. L., G. M. Glenn, J. P. Wagner, I. A. Lubensky, K. Thakore, B. Zbar, W. M. Linehan, and M. M. Walther. 1997. Epididymal cystadenomas in von Hippel-Lindau disease. Urology 49:926–931.
  • Eckert, R. L., J. F. Crish, T. Efimova, S. R. Dashti, A. Deucher, F. Bone, G. Adhikary, G. Huang, R. Gopalakrishnan, and S. Balasubramanian. 2004. Regulation of involucrin gene expression. J. Investig. Dermatol. 123:13–22.
  • Fuchs, E. 1995. Keratins and the skin. Annu. Rev. Cell Dev. Biol. 11:123–153.
  • Gilcrease, M. Z., L. Schmidt, B. Zbar, L. Truong, M. Rutledge, and T. M. Wheeler. 1995. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum. Pathol. 26:1341–1346.
  • Gläsker, S., R. R. Lonser, M. G. Tran, B. Ikejiri, J. A. Butman, W. Zeng, P. H. Maxwell, Z. Zhuang, E. H. Oldfield, and A. O. Vortmeyer. 2005. Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res. 65:10847–10853.
  • Gläsker, S., M. G. Tran, S. B. Shively, B. Ikejiri, R. R. Lonser, P. H. Maxwell, Z. Zhuang, E. H. Oldfield, and A. O. Vortmeyer. 2006. Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymis. J. Pathol. 210:32–41.
  • Grisanzio, C., and S. Signoretti. 2007. p63 in prostate biology and pathology. J. Cell Biochem. 103:1354–1368.
  • Gustafsson, M. V., X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J. L. Ruas, L. Poellinger, U. Lendahl, and M. Bondesson. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9:617–628.
  • Haase, V. H., J. N. Glickman, M. Socolovsky, and R. Jaenisch. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98:1583–1588.
  • Hayashi, T., A. Yoshinaga, R. Ohno, N. Ishii, S. Kamata, and T. Yamada. 2004. Expression of the p63 and Notch signaling systems in rat testes during postnatal development: comparison with their expression levels in the epididymis and vas deferens. J. Androl. 25:692–698.
  • Jhappan, C., D. Gallahan, C. Stahle, E. Chu, G. H. Smith, G. Merlino, and R. Callahan. 1992. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 6:345–355.
  • Kim, W. Y., and W. G. Kaelin. 2004. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22:4991–5004.
  • Koster, M. I., S. Kim, A. A. Mills, F. J. DeMayo, and D. R. Roop. 2004. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18:126–131.
  • Leone, D. P., J. B. Relvas, L. S. Campos, S. Hemmi, C. Brakebusch, R. Fassler, C. Ffrench-Constant, and U. Suter. 2005. Regulation of neural progenitor proliferation and survival by beta1 integrins. J. Cell Sci. 118:2589–2599.
  • Lesche, R., M. Groszer, J. Gao, Y. Wang, A. Messing, H. Sun, X. Liu, and H. Wu. 2002. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32:148–149.
  • Leslie, N. R., X. Yang, C. P. Downes, and C. J. Weijer. 2005. The regulation of cell migration by PTEN. Biochem. Soc. Trans. 33:1507–1508.
  • Leung, S. Y., A. S. Chan, M. P. Wong, S. T. Yuen, Y. W. Fan, and L. P. Chung. 1998. Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis. Hum. Pathol. 29:1322–1324.
  • Lonser, R. R., G. M. Glenn, M. Walther, E. Y. Chew, S. K. Libutti, W. M. Linehan, and E. H. Oldfield. 2003. von Hippel-Lindau disease. Lancet 361:2059–2067.
  • Lowell, S., P. Jones, I. Le Roux, J. Dunne, and F. M. Watt. 2000. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr. Biol. 10:491–500.
  • Lupien, M., A. Dievart, C. R. Morales, L. Hermo, E. Calvo, D. G. Kay, C. Hu, and P. Jolicoeur. 2006. Expression of constitutively active Notch1 in male genital tracts results in ectopic growth and blockage of efferent ducts, epididymal hyperplasia and sterility. Dev. Biol. 300:497–511.
  • Maehama, T., and J. E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375–13378.
  • Mandriota, S. J., K. J. Turner, D. R. Davies, P. G. Murray, N. V. Morgan, H. M. Sowter, C. C. Wykoff, E. R. Maher, A. L. Harris, P. J. Ratcliffe, and P. H. Maxwell. 2002. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1:459–468.
  • Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
  • Mills, A. A., B. Zheng, X. J. Wang, H. Vogel, D. R. Roop, and A. Bradley. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708–713.
  • Mori, S., Y. Kadokawa, K. Hoshinaga, and T. Marunouchi. 2003. Sequential activation of Notch family receptors during mouse spermatogenesis. Dev. Growth Differ. 45:7–13.
  • Nguyen, B. C., K. Lefort, A. Mandinova, D. Antonini, V. Devgan, G. Della Gatta, M. I. Koster, Z. Zhang, J. Wang, A. Tommasi di Vignano, J. Kitajewski, G. Chiorino, D. R. Roop, C. Missero, and G. P. Dotto. 2006. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20:1028–1042.
  • Nickoloff, B. J., J. Z. Qin, V. Chaturvedi, M. F. Denning, B. Bonish, and L. Miele. 2002. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ. 9:842–855.
  • Pastorekova, S., Z. Zavadova, M. Kostal, O. Babusikova, and J. Zavada. 1992. A novel quasi-viral agent, MaTu, is a two-component system. Virology 187:620–626.
  • Pedrero, J. M., D. G. Carracedo, C. M. Pinto, A. H. Zapatero, J. P. Rodrigo, C. S. Nieto, and M. V. Gonzalez. 2005. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int. J. Cancer 114:242–248.
  • Podsypanina, K., L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher, and R. Parsons. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96:1563–1568.
  • Pollard, P. J., B. Spencer-Dene, D. Shukla, K. Howarth, E. Nye, M. El-Bahrawy, M. Deheragoda, M. Joannou, S. McDonald, A. Martin, P. Igarashi, S. Varsani-Brown, I. Rosewell, R. Poulsom, P. Maxwell, G. W. Stamp, and I. P. Tomlinson. 2007. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 11:311–319.
  • Rangarajan, A., C. Talora, R. Okuyama, M. Nicolas, C. Mammucari, H. Oh, J. C. Aster, S. Krishna, D. Metzger, P. Chambon, L. Miele, M. Aguet, F. Radtke, and G. P. Dotto. 2001. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20:3427–3436.
  • Saito, K., S. Kawakami, Y. Okada, R. Takazawa, F. Koga, Y. Kageyama, and K. Kihara. 2006. Spatial and isoform specific p63 expression in the male human urogenital tract. J. Urol. 176:2268–2273.
  • Shao, X., S. Somlo, and P. Igarashi. 2002. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 13:1837–1846.
  • Shen, T., Z. Zhuang, D. J. Gersell, and F. A. Tavassoli. 2000. Allelic deletion of VHL gene detected in papillary tumors of the broad ligament, epididymis, and retroperitoneum in von Hippel-Lindau disease patients. Int. J. Surg. Pathol. 8:207–212.
  • Shin, K. H., J. M. Kim, K. S. Rho, K. H. Park, J. E. Oh, and B. M. Min. 2002. Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas. Int. J. Oncol. 21:997–1001.
  • Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70–71.
  • Stambolic, V., M. S. Tsao, D. Macpherson, A. Suzuki, W. B. Chapman, and T. W. Mak. 2000. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res. 60:3605–3611.
  • Suh, E. K., A. Yang, A. Kettenbach, C. Bamberger, A. H. Michaelis, Z. Zhu, J. A. Elvin, R. T. Bronson, C. P. Crum, and F. McKeon. 2006. p63 protects the female germ line during meiotic arrest. Nature 444:624–628.
  • Tachibana, M., M. Shibakita, S. Ohno, S. Kinugasa, H. Yoshimura, S. Ueda, T. Fujii, M. A. Rahman, D. K. Dhar, and N. Nagasue. 2002. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 94:1955–1960.
  • Takahashi, K., M. Murakami, and S. Yamanaka. 2005. Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem. Soc. Trans. 33:1522–1525.
  • Thoma, C. R., I. J. Frew, C. R. Hoerner, M. Montani, H. Moch, and W. Krek. 2007. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat. Cell Biol. 9:588–595.
  • Vivanco, I., N. Palaskas, C. Tran, S. P. Finn, G. Getz, N. J. Kennedy, J. Jiao, J. Rose, W. Xie, M. Loda, T. Golub, I. K. Mellinghoff, R. J. Davis, H. Wu, and C. L. Sawyers. 2007. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 11:555–569.
  • Vortmeyer, A. O., M. G. Tran, W. Zeng, S. Glasker, C. Riley, M. Tsokos, B. Ikejiri, M. J. Merrill, M. Raffeld, Z. Zhuang, R. R. Lonser, P. H. Maxwell, and E. H. Oldfield. 2006. Evolution of VHL tumourigenesis in nerve root tissue. J. Pathol. 210:374–382.
  • Vortmeyer, A. O., Q. Yuan, Y. S. Lee, Z. Zhuang, and E. H. Oldfield. 2004. Developmental effects of von Hippel-Lindau gene deficiency. Ann. Neurol. 55:721–728.
  • Wang, S., A. J. Garcia, M. Wu, D. A. Lawson, O. N. Witte, and H. Wu. 2006. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc. Natl. Acad. Sci. USA 103:1480–1485.
  • Wang, X. D., C. C. Leow, J. Zha, Z. Tang, Z. Modrusan, F. Radtke, M. Aguet, F. J. de Sauvage, and W. Q. Gao. 2006. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev. Biol. 290:66–80.
  • Wilson, J. D. 1978. Sexual differentiation. Annu. Rev. Physiol. 40:279–306.
  • Yang, A., R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R. T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.